TranscriptsNov 07, 2026, 10:14 PM ETSarepta Therapeutics, Inc. (SRPT) StockSA Transcripts162.91K FollowersSarepta Therapeutics, Inc. (SRPT) Q3 2026 Earnings Call November 5, 2026 4:30 PM ESTCompany ParticipantsTamara Thornton - Director of Finance, Treasury & Investor RelationsMichael Severino - CEO & DirectorPatrick Moss - Executive VP & Chief Commercial OfficerLouise Rodino-Klapac - President of Research & Development and Technical OperationsRyan Wong - Executive VP & CFOJames Richardson - Executive VP & Chief Medical OfficerConference Call ParticipantsAdhiraj Chauhan - JPMorgan Chase & Co, Research DivisionKonstantinos Biliouris - Oppenheimer & Co. Inc., Research DivisionBrian Abrahams - RBC Capital Markets, Research DivisionLin Tsai - Jefferies LLC, Research DivisionEliana Merle - Barclays Bank PLC, Research DivisionJoshua Fleishman - TD Cowen, Research DivisionBrian Skorney - Robert W. Baird & Co. Incorporated, Research DivisionJoseph Schwartz - Leerink Partners LLC, Research DivisionYanan Zhu - Wells Fargo Securities, LLC, Research DivisionDavid Hoang - Deutsche Bank AG, Research DivisionTommie Reerink - Goldman Sachs Group, Inc., Research DivisionTazeen Ahmad - BofA Securities, Research DivisionLachlan Hanbury-Brown - William Blair & Company L.L.C., Research DivisionJason Zhang - Wolfe Research, LLCJonathan NudlerPresentationOperatorGood afternoon, and welcome to Sarepta's Third Quarter 2026 Earnings Results Call.As a reminder, today's program is being recorded. At this time, I'll turn the call over to Tam Thornton, Senior Director of Investor Relations. Please go ahead.Tamara ThorntonDirector of Finance, Treasury & Investor RelationsThank you, Michelle, and thank you all for joining today's call.Earlier this afternoon, we released our financial results for the third quarter of 2026. The press release, along with our presentation slides and supplementary information are available on the Investors section of our company website. We plan to file our Form 10-Q for the quarter today with the SEC.Joining me on the call today are Mike Severino, our Chief Executive Officer; Dr. Louise Rodino-Klapac, President of Research and Development andRead more current SRPT analysis and newsView all earnings call transcriptsComments